WithdrawnNCT01587066
Efficacy of Quetiapine XR Versus Divalproex on Clinical Outcome Quality of Sleep and Quality of Life in Depression in bipolarity
Medication studyAges 20–65South Korea
Understand this study
Who could participate?
Listed age limits: 20 years to 65 years.
- Listed locations
- NajuSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateAugust 2010
- Recruitment status
- Withdrawn
- Enrollment listed in the registry
- 0
- Sponsor
- Bo-Hyun Yoon
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- South Korea
- Age range
- From 20 Years to 65 Years
- Official registry ID
- NCT01587066
- Official title
Show the full official title
Efficacy of Quetiapine XR Versus Divalproex on Clinical Outcome Quality of Sleep and Quality of Life in Bipolar Depression
Recruitment & locations
WithdrawnThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Naju
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Bo-Hyun Yoon.
Does this study involve medication?
Yes. The study involves medication, including Quetiapine fumarate and Divalproex sodium.
Who can participate?
Listed age limits: 20 years to 65 years.
Is this study still recruiting?
The registry lists this study as withdrawn.
